ATX and LPA receptor 3 are coordinately up-regulated in lipopolysaccharide-stimulated THP-1 cells through PKR and SPK1-mediated pathways  by Li, Song et al.
FEBS Letters 586 (2012) 792–797journal homepage: www.FEBSLetters .orgATX and LPA receptor 3 are coordinately up-regulated in lipopolysaccharide-
stimulated THP-1 cells through PKR and SPK1-mediated pathways
Song Li 1, Chaoyang Xiong 1, Junjie Zhang ⇑
The Key Laboratory for Cell Proliferation and Regulation Biology of Ministry of Education, College of Life Sciences, Beijing Normal University, Beijing 100875, China
a r t i c l e i n f oArticle history:
Received 3 November 2011
Revised 30 December 2011
Accepted 20 January 2012
Available online 2 February 2012







CCL80014-5793/$36.00  2012 Federation of European Bio
doi:10.1016/j.febslet.2012.01.044
Abbreviations: LPS, lipopolysaccharide; ATX, auto
acid; LPC, lysophosphatidylcholine; PKR, protein kina
Jun N-terminal kinase; ERK, extracellular signal-regul
kinase
⇑ Corresponding author. Fax: +86 10 58807720.
E-mail address: jjzhang@bnu.edu.cn (J. Zhang).
1 These authors contributed equally to this paper.a b s t r a c t
Lysophosphatidic acid (LPA) is an important phospholipid mediator in inﬂammation and immunity.
Previously, we showed that autotaxin (ATX), the enzyme producing LPA from lysophosphatidylcho-
line (LPC), is induced by LPS in THP-1 cells via the activation of PKR, JNK and p38 MAPK. In this study,
we ﬁnd that ATX and LPA receptor 3 (LPA3) are coordinately up-regulated in LPS-stimulated THP-1
cells. PKR-mediated activation of JNK1 and p38 MAPK is required for both ATX and LPA3 up-regula-
tion. SPK1-mediated activation of the PI3K-AKT-b-catenin pathway is essential for ATX induction,
while SPK1-mediated ERK activation is required for LPA3 up-regulation. Either ATX or LPA3 knock-
down inhibited CCL8 induction by LPS, suggesting that ATX and LPA3 are involved in CCL8 induction
during the inﬂammatory process against bacterial infection.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Autotaxin (ATX) is a secreted glycoprotein with lysophospholi-
pase D activity to convert lysophosphatidylcholine (LPC) into the
bioactive phospholipid lysophosphatidic acid (LPA) [1]. ATX is
made of two somatomedin B-like (SMB) domains, followed by a cat-
alytic domain and a nuclease-like domain [2,3]. ATX deﬁciency in
mouse leads to embryonic lethality, while ATX heterozygous mice
appear healthy but show half-normal plasma LPA levels, indicating
that ATX is the major LPA-producing enzyme in vivo and required
for normal development [4,5]. ATX is regarded as an attractive tar-
get in cancer therapy, as a strong association between cancer and
ATX expression has been observed during the past decades [6,7].
Recently, emerging data have indicated an important role of ATX
in regulating immune responses. For instance, ATX is highly ex-
pressed in the high endothelial venules (HEVs) of lymphoid organs
to facilitate the entry of lymphocytes from the blood into secondary
lymphoid organs [8].chemical Societies. Published by E
taxin; LPA, lysophosphatidic
se regulated by RNA; JNK, c-
ated kinase; SPK, sphingosineMost, if not all of, biological functions of ATX are performed via
the LPA signaling mediated through the speciﬁc LPA receptors on
cellmembrane [9]. So far, there are ﬁve G protein-coupled receptors
(GPCRs) identiﬁed as speciﬁc receptors for LPA, LPA1/EDG2, LPA2/
EDG4, LPA3/EDG7, LPA4/P2Y9 and LPA5/GPR92. In addition, recent
reports have suggested that three additional GPCRs, GPCR87, P2Y5
and P2Y10,may be response to LPA [10]. The broad range of LPA cel-
lular functions is accomplished by several LPA receptors differen-
tially coupled to distinct G proteins (Gq, Gi and G12/13), through
which various downstream signaling molecules, including phos-
pholipase C, PI3K, Ras-MAPK and Rho, are activated [11]. LPA is
an important phospholipid mediator in inﬂammation and immu-
nity, to modulate immune responses by attracting and activating
immune cells directly or inﬂuencing their interaction with other
cells [12,13]. However, the mechanism by which LPA signaling is
regulated during inﬂammation and immune responses remains to
be explored.
Lipopolysaccharide (LPS), a component of the gram-negative
bacterial cell wall, functions as a potent initiator of inﬂammatory
response. LPS stimulation of monocytes/macrophages effects the
generation of a number of inﬂammatory mediators. We have pre-
viously demonstrated that LPS induces ATX expression in human
monocytic THP-1 cell and that the activation of PKR, JNK and p38
MAPK is required for the ATX induction [14]. In this study, it is
found that LPS induces both ATX and LPA3 expression in human
monocytic THP-1 cells. The PKR and SPK1-mediated pathwayslsevier B.V. All rights reserved.
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dinate up-regulation of these two genes. In addition, either ATX or
LPA3 knockdown inhibits the induction of CCL8, a key chemokine
in inﬂammation response. We propose that ATX–LPA–LPA3 signal-
ing is enhanced in LPS-stimulated monocytic cells and involved in
the CCL8 expression regulation during inﬂammatory process
against bacterial infection.
2. Materials and methods
2.1. Reagents and antibodies
LPS (from Escherichia coli serotype 055:B5), and GSK3b inhibitor
SB216763 were purchased from Sigma–Aldrich (Saint Louis, MI,
USA). PI3-kinase inhibitor LY294002, wortmannin, SPK inhibitor
N,N-dimethylsphingosine (DMS), and ERK inhibitor PD98059, were
from Calbiochem (La Jolla, CA). Ki16425 was from Cayman Chem-
ical (Ann Arbor, MI). The ATX inhibitor S32826 was form Echelon
Biosciences (Salt Lake City, Utah).
The autotaxin antibody was produced as described [14].
The antibodies against phosphorylated JNK(Thr183/Tyr185), p38
MAPK(Thr180/Tyr182), ERK(Thr202/Tyr204), p85(Tyr458), AKT(Ser473),
as well as the antibodies against total ERK, p38 MAPK, p85, AKT,
b-catenin and b-actin were purchased from Cell Signaling Technol-
ogy (Beverly, MA). The antibody against phosphorylated PKR
(Thr451) was from Upstate Biotechnology (Lake Placid, NY). The
antibodies against total JNK and PKRwere from Santa Cruz Biotech-
nology (Santa Cruz, CA).
2.2. Cell culture, siRNA and transfection
The THP-1 cells were cultured in RPMI-1640 medium(Gibco)
supplemented with 10% fetal bovine serum (Hyclone), 2 mM L-glu-
tamine (Gibco), 100 lg/ml streptomycin (Gibco) and 100 U/ml
penicillin (Gibco) at 37 C in a humidiﬁed atmosphere containing
5% CO2. The non-speciﬁc siRNA (si-NC) and siRNAs speciﬁc to
PKR, AKT, b-catenin, SPK1, SPK2, ATX, LPA1, LPA2, LPA3, JNK1, and
JNK2 were synthesized by GenePharma (Shanghai, China). The tar-
get sequences of these siRNAs were listed in Table S1. The p38
MAPK, ERK1 and ERK2 siRNAs were purchased from Santa CruzFig. 1. PKR-mediated activation of JNK1 and p38 is required for ATX induction by LPS. T
indicated gene, and then subjected to LPS stimulation 36 h post siRNA transfection. Total
after LPS treatment for 30 min. ATX protein secreted in culture medium (40-fold concent
RT-PCR (C) or real-time RT-PCR (D) after LPS treatment for16 h.Biotechnology. The siRNA transfection was performed with lipo-
fectamine 2000 (Invitrogen) according to manufacturer’s protocol.
2.3. RT-PCR and real-time RT-PCR
Total RNA was extracted with Trizol (Invitrogen). Reverse tran-
scription was performed with Reverse Transcription System
(Promega). cDNA encoding indicated genes were ampliﬁed using
speciﬁc primers as listed in Table S2. The real-time RT-PCR was
performed using the iQ SYBR Green Supermix (Bio-Rad) with the
iCycler iQ real-time PCR detection system (Bio-Rad). Relative
expression of each gene was estimated by normalization with
the expression of GAPDH.
2.4. Western blotting
Western blotting analysis was performed as described previ-
ously [14].
2.5. Statistical analysis
Results are expressed as means ± SE and signiﬁcance was deter-
mined by analysis by Student’s t-test for two-group comparison
(⁄P < 0.001).
3. Results and discussion
3.1. PKR-mediated activation of JNK1 and p38 MAPK is required for the
ATX induction by LPS
Bacterial lipopolysaccharide (LPS) is a well-known initiator of
inﬂammatory responses. We had reported that LPS induced ATX
expression in monocytic THP-1 cells, which was suppressed when
PKR, JNK or p38 MAPK activation was inhibited by its speciﬁc
inhibitor [14]. In present study, PKR, p38 and JNK1/2 were down-
regulated with their speciﬁc siRNA, respectively. PKR knockdown
attenuated the LPS induced activation of JNK and p38 MAPK, but
had no signiﬁcant effects on ERK activation (Fig. 1A). PKR siRNA
inhibited the ATX induction by LPS in a dose-dependent manner
(Fig. 1C). In addition, p38 siRNA and JNK1 siRNA, but not JNK2HP-1 cells were transfected with the scrambled siRNA (si-NC) or siRNA speciﬁc to
and phosphorylated PKR, p38 and JNK (A and B) were detected by Western blotting
rated) was detected by Western blotting (C) and ATX mRNA levels were detected by
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These results indicate that PKR functions as an up-stream regulator
of JNK and p38 MAPK activation and that the PKR-mediated activa-
tion of JNK1 and p38 MAPK is required for the ATX induction in
LPS-stimulated THP-1 cells. ERK1/ERK2 siRNAs could not block
the ATX induction (Fig. S1), suggesting that ERK activation was
not involved in the ATX induction by LPS.
3.2. Activation of PI3K-AKT-b-catenin pathway is required for the ATX
induction by LPS
PI3K and AKT activation were detected rapidly in THP-1 cells
after the LPS stimulation, andAKTknockdownreduced theb-catenin
stability and nuclear b-catenin accumulation in LPS-stimulated
THP-1 cells (Fig. S2), indicating that the PI3K–AKT–b-catenin path-
way is activated by LPS. It was found that PI3K inhibitor LY294002,
as well as AKT siRNA and b-catenin siRNA, blocked the LPS-induced
ATX expression in a dose-dependentmanner (Fig. 2A–C), suggesting
that PI3K–AKT–b-catenin pathway activation is required for theATX
induction. AKT can phosphorylate and deactivate GSK3b, while the
non-phosphorylated GSK3b is active and phosphorylates b-catenin,
leading to b-catenin degradation in the ubiquitin-dependent prote-
osome pathway [15]. SB216763, a selective inhibitor of GSK3b in-
creased b-catenin accumulation in THP-1 cells without LPS
stimulation (Fig. 2D). Moreover, the LPS-induced ATX expression
could not be attenuated by AKT siRNA when THP-1 cells were pre-
treated with SB216763 (Fig. 2E). Therefore, b-catenin is activated
by PI3K–AKT pathway through GSK3b deactivation, and plays a role
to elevate ATX transcription levels in LPS-stimulated THP-1 cells.
3.3. SPK1 is essential for the ATX induction as the up-stream regulator
of PI3K-AKT-b-catenin pathway
SPK is a key enzyme catalyzing the formation of sphingosine-1-
phosphate (S1P), a lipid messenger that is implicated in theFig. 2. Activation of PI3K–AKT–b-catenin signaling pathway is required for ATX inductio
with AKT (B) and b-catenin siRNA (C), respectively. ATX mRNA and protein levels were de
1 cells treated with or without GSK3b inhibitor SB216763 for indicated time. (E) THP-1 c
or without SB216763 for 1 h prior to the LPS stimulation. After LPS treatment for 16 h,regulation of a wide variety of important cellular events [16]. The
SPK activation under LPS treatment or other conditions in immune
cells has been previously reported [17]. DMS, a potent SPK inhibi-
tor, blocked the LPS-induced ATX expression in a dose-dependent
manner (Fig. 3A). There are two SPK isoforms in mammalian cells,
SPK1 and SPK2. Both SPK1 and SPK2 mRNA expressions were de-
tected in THP-1 cells. The endogenous SPK1 and SPK2 expression
in THP-1 cells could be suppressed by their speciﬁc siRNAs, respec-
tively (Fig. 3B). The SPK1-speciﬁc, but not SPK2-speciﬁc siRNA,
blocked LPS-induced ATX expression in THP-1 cells (Fig. 3C), indi-
cating that SPK1 activation is required for the ATX induction. The
inhibition of LPS-induced ATX expression by SPK1 siRNA was not
reversed by the addition of S1P in culture medium (Fig. S3), sug-
gesting that the effect of SPK1 on ATX induction is not dependent
on extracellular S1P.
As both PI3K–AKT–b-catenin and PKR–MAPKs pathways are in-
volved in the ATX induction by LPS, we examined the effects of
SPK1 on these two signaling pathways. Down-regulation of SPK1
inhibited the activation of PI3K and AKT, resulting in the decrease
of b-catenin stability, but did not block the activation of PKR, p38
and JNK (Fig. 3D). These data indicate that SPK1 involved in the
ATX induction as an up-stream regulator of the PI3K–AKT–b-
catenin pathway. Furthermore, with the ability to disrupt PKR–
MAPKs pathway, PKR knockdown had no signiﬁcant effects on
the PI3K and AKT activation, and did not decrease the stability of
b-catenin in LPS-stimulated THP-1 cells (Fig. S4). Therefore,
SPK1–PI3K–AKT–b-catenin and PKR–MAPKs are two essential but
independent signaling pathways involved in the ATX induction.
3.4. LPA3 expression is up-regulated by LPS through PKR-mediated
JNK1 and p38 MAPK activation and SPK1-mediated ERK activation
The expression levels of LPA receptors in THP-1 cells were
examined. Three major LPA receptors, LPA1, LPA2 and LPA3, were
all expressed in resting THP-1 cells, with the lowest expressionn by LPS. THP-1 cells were pretreated for 30 min with LY294002 (A) or transfected
tected after LPS treatment for 16 h. (D) Total b-catenin protein was detected in THP-
ells were transfected with scrambled siRNA (si-NC) or si-AKT, and then treated with
ATX mRNA levels were detected by real-time RT-PCR.
Fig. 3. SPK1 is essential for the ATX induction in LPS-stimulated THP-1 cells. (A) THP-1 cells were pretreated with indicated amounts of SPK inhibitor DMS for 30 min and
then subjected to LPS stimulation. ATX mRNA and protein levels were detected after 16 h LPS treatment. (B and C) THP-1 cells were transfected with SPK1, SPK2 or scrambled
siRNA (si-NC). SPK1 and SPK2 knockdown were conﬁrmed by RT-PCR (B). ATX mRNA levels in the transfected cells were measured by real-time RT-PCR after 16 h LPS
treatment (C). (D) Total and phosphorylated PI3K p85 regulatory subunit, AKT, PKR, p38 and JNK in the SPK1 siRNA-transfected THP-1 cells were detected after LPS treatment
for 30 min, and total b-catenin was detected after LPS treatment for 2 h.
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transcriptional expression level after LPS stimulation (Fig. 4A). LPS
induced LPA3 expression in a dose- and time-dependent manner.
LPA3 mRNA levels was up-regulated after 8 h LPS stimulation and
then persistent in the differentiated THP-1 cells (Fig. S5). The signal-
ing pathways involved in the LPA3 up-regulation were investigated.
It was found that the LPA3 up-regulation was blocked by the PKR,
p38 and JNK1 siRNA respectively, but not by JNK2 speciﬁc siRNA
(Fig. 4B), indicating that the PKR-mediated activation of JNK1 and
p38 MAPK is required for the LPA3 up-regulation. Furthermore,
LPA3 up-regulation by LPS was suppressed by SPK1 siRNA, but not
by SPK2 siRNA (Fig. 4B). However, AKT siRNA and b-catenin siRNA
had no effects on LPA3 up-regulation (Fig. 4B), and PI3K inhibitorsFig. 4. LPS induces LPA3 expression through PKR-mediated JNK1 and p38 MAPK activatio
in THP-1 cells were detected by real-time RT-PCR after LPS (1 lg/ml) treatment for indica
were detected by real-time RT-PCR after 16 h LPS treatment. (C) ERK activation was dete
and E) THP-1 cells were transfected with ERK1, ERK2 or scrambled siRNA (si-NC). ERK1 a
the transfected cells were measured by real-time RT-PCR after 16 h LPS treatment (E).LY294002 and wortmannin also could not block the up-regulation
of LPA3 (data not shown), suggesting that PI3K–AKT–b-catenin sig-
naling pathway is not involved in the LPA3 up-regulation by LPS. On
the other hand, SPK1 siRNA attenuated ERK1/2 phosphorylation
(Fig. 4C), and LPS-induced LPA3 up-regulationwas signiﬁcantly sup-
pressed by either ERK1 or ERK2 siRNA (Fig. 4D and E). In conclusion,
PKR-mediated JNK1 and p38 MAPK activation and SPK1-mediated
ERK1/2 activation, but not PI3K-AKT pathway activation, are re-
quired for the LPA3 up-regulation in LPS-stimulated THP-1 cells.
LPA1 and LPA2 were also up-regulated in the LPS-stimulated THP-1
cells. It is found that both LPA1 and LPA2 up-regulation were depen-
dent on the activation of PKR, p38 and JNK, but not the activation of
SPK1, PI3K and ERK (Fig. S6).n and SPK1-mediated ERK activation. (A) The mRNA levels of LPA receptor 1, 2 and 3
ted times. (B) LPA3 mRNA levels in the THP-1 cells transfected with indicated siRNA
cted in the SPK1 siRNA-transfected THP-1 cells after LPS stimulation for 30 min. (D
nd ERK2 knockdown were conﬁrmed by Western blotting (D). ATX mRNA levels in
Fig. 5. ATX and LPA3 are involved in the CCL8 induction in LPS-stimulated THP-1 cells. (A) CCL8 mRNA levels in THP-1 cells were detected by RT-PCR after LPS treatment for
16 h in the presence or absence of ATX inhibitor S32826. (B) THP-1 cells were transfected with scrambled siRNA (siNC) and ATX siRNA (si-ATX) respectively. CCL8 mRNA
levels in the transfected cells were detected by real-time RT-PCR after 16 h LPS treatment. (C) THP-1 cells were pretreated with or without LPA receptor antagonist Ki16425
(5 lM) and then subjected to LPS stimulation. CCL8 mRNA levels were detected by real-time RT-PCR after 16 h LPS treatment. (D and E) THP-1 cells were transfected with
LPA1, LPA2 or LPA3 siRNA. LPA1, LPA2 and LPA3 knockdown were conﬁrmed respectively (D), and CCL8 mRNA levels were detected by real-time PCR after 16 h LPS treatment
(E).
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activation of JNK1 and p38 and SPK1-mediated activation of
PI3K–AKT–b-catenin pathway. With PKR and SPK1 as the common
up-stream regulators of expression regulation pathways, ATX, a
major enzyme for LPA production, and LPA3, one of the major
LPA receptors, are coordinately up-regulation by LPS in THP-1 cells.
The coordinate up-regulation of ATX and LPA3 by LPS may enhance
the ATX–LPA–LPA3 signaling in monocytic cells in response to bac-
terial infection (Fig. S7).
3.5. ATX and LPA3 are involved in CCL8 induction in LPS-stimulated
THP-1 cells
Chemokine (C-C motif) ligand 8 (CCL8), also known as MCP-2, is
chemotactic for and activatesmany different immune cells involved
in the inﬂammatory response. CCL8 was induced in THP-1 mono-
cytic cells in response to LPS stimulation. It was found that suppres-
sion of ATX lysoPLD activity by its inhibitor S32826 disrupted the
CCL8 inductionby LPS (Fig. 5A). ATXknockdownwith its speciﬁc siR-
NA also inhibited the CCL8 induction (Fig. 5B). However, LPA itself
could not induce CCL8 in THP-1 cells without LPS stimulation (data
not shown).When theATX lysoPLDactivity in the culturemediumof
the LPS-stimulated THP-1 cells was inhibited to the basal level by
S32826 (1 lM), the CCL8 induction by LPS was dramatically sup-
pressed, but CCL8mRNA expression was still at a much higher level
than that in the control cellswithout LPS stimulation (Fig. S8). These
data suggest that the ATX–LPA plays a role to enhance the CCL8
induction by LPS in THP-1 cells. Furthermore, the induction of
CCL8 was inhibited by Ki16425 (5 lM), a LPA receptor antagonist
(Fig. 5C).When LPA1, LPA2 and LPA3were down-regulatedwith their
speciﬁc siRNAs respectively, the CCL8 induction was suppressed by
LPA3 siRNA, but not LPA1 and LPA2 siRNA (Fig. 5D and E). Therefore,
ATX-LPA is involved in the CCL8 induction in LPS-stimulated THP-1
cells through the LPA3-mediated signaling.LPA is an important phospholipid mediator in inﬂammation and
immunity with the capacity to evoke and modulate immune re-
sponses by attracting and activating monocytes, macrophages, T-
cells and B-cells and other immune cells directly and inﬂuencing
their interactions with other cell types [12,13,18]. However, the
mechanism to regulate LPA signaling during inﬂammation process
remains unclear. Human monocytic THP-1 cells differentiate to
macrophage-like cells under LPS treatment, which imitates the
monocytes-macrophages process in response to bacterial infection.
In present study, we demonstrated that ATX and LPA3 were coordi-
nately up-regulated in LPS-stimulated THP-1 cells through PKR and
SPK1-mediated pathways. With its lysoPLD activity, the increased
ATX would elevate the LPA levels in the microenvironment to pro-
mote LPA signaling mediated by LPA receptors. Regarding to coor-
dinate up-regulation of ATX and LPA3 and their roles in the
induction of CCL8, a key chemokine in the inﬂammatory response,
the ATX–LPA–LPA3 signaling would participate in the regulation of
immune activities during inﬂammation response against bacterial
infection. More functions of the enhanced ATX-LPA signaling med-
iated by LPA3, as well as by other LPA receptors on monocytes/
macrophages, in inﬂammation and immunity remain to be further
studied.
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